Synlogic (SYBX) Tops Q4 EPS by 7c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Synlogic Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
March 12, 2019 7:00 AM EDTEnded 2018 with approximately $123 million in cash and investments, which provides runway through 2020
Clinical trial readouts expected in mid-2019 from two Synthetic Biotic medicines and first IND application expected from Synlogics immuno-oncology platform in second half of 2019
Company will host a conference call and webcast at 8:00 am ET today
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Synlogic, Inc.... More
